Shruti Koulgi

Ms. Shruti Koulgi

Centre for Development of Advanced Computing (C-DAC)
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKShruti Koulgi
Shruti Koulgi
VJVinod Jani
Vinod Jani
MUMallikarjunachari V. N. Uppuladinne
Mallikarjunachari V. N. Uppuladinne
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi
The efforts towards developing a potential drug against the current global pandemic, COVID-19, have increased in the past few months. Drug development strategies to target the RNA dependent RNA polymerase (RdRP) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are being tried worldwide. The gene encoding this protein, is known to be conserved amongst positive strand RNA viruses. This enables an avenue to repurpose the drugs designed against earlier reported inhibitors of RdRP. One such strong inhibitor is remdesivir which has been used against EBOLA infections. The binding of remdesivir to RdRP of SARS-CoV-2 has been studied using the classical molecular dynamics and ensemble docking approach. A comparative study of the simulations of RdRP in the apo and remdesivir-bound form revealed blocking of the template entry site in the presence of remdesivir. The conformation changes leading to this event were captured through principal component analysis. The conformational and thermodynamic parameters supported the experimental information available on the involvement of crucial arginine, serine and aspartate residues belonging to the conserved motifs in RdRP functioning. The catalytic site comprising of SER 759, ASP 760, and ASP 761 (SDD) was observed to form strong contacts with remdesivir. The significantly strong interactions of these residues with remdesivir may infer the latter's binding similar to the normal nucleotides thereby remaining unidentified by the exonuclease activity of RdRP. The ensemble docking of remdesivir too, comprehended the involvement of similar residues in interaction with the inhibitor. This information on crucial interactions between conserved residues of RdRP with remdesivir through in silico approaches may be useful in designing inhibitors.

21 November 2013 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
SKShruti Koulgi
Shruti Koulgi
AAArchana Achalere
Archana Achalere
NSNeeru Sharma
Neeru Sharma
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi

1 November 2010 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
SKShruti Koulgi
Shruti Koulgi
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi

18 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SKShruti Koulgi
Shruti Koulgi
AAArchana Achalere
Archana Achalere
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi
The tp53 gene is found to be mutated in 50% of all the cancers. The p53 protein, a product of tp53 gene, is a multi-domain protein. It consists of a core DNA binding domain (DBD) which is responsible for its binding and transcription of downstream target genes. The mutations in p53 protein are responsible for creating cancerous conditions and are found to be occurring at a high frequency in the DBD region of p53. Some of these mutations are also known to be temperature sensitive (ts) in nature. They are known to exhibit partial or strong binding with DNA in the temperature range (298–306 K). Whereas, at 310 K and above they show complete loss in binding. We have analyzed the changes in binding and conformational behavior at 300 K and 310 K for three of the ts-mutants viz., V143A, R249S and R175H. QM-MM simulations have been performed on the wild type and the above mentioned ts-mutants for 30 ns each. The optimal estimate of free energy of binding for a particular number of interface hydrogen bonds was calculated using the maximum likelihood method as described by Chodera et. al (2007). This parameter has been observed to be able to mimic the binding affinity of the p53 ts-mutants at 300 K and 310 K. Thus the correlation between MM-GBSA free energy of binding and hydrogen bonds formed by the interface residues between p53 and DNA has revealed the temperature dependent nature of these mutants. The role of main chain dihedrals was obtained by performing dihedral principal component analysis (PCA). This analysis, suggests that the conformational variations in the main chain dihedrals (ϕ and ψ) of the p53 ts-mutants may have caused reduction in the overall stability of the protein. The solvent exposure of the side chains of the interface residues were found to hamper the binding of the p53 to the DNA. Solvent Accessible Surface Area (SASA) also proved to be a crucial property in distinguishing the conformers obtained at 300 K and 310 K for the three ts-mutants from the wild type at 300 K.

26 May 2022 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
SKShruti Koulgi
Shruti Koulgi
AAArchana Achalere
Archana Achalere
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi

26 October 2018 in Journal of Computational Chemistry
Verified
Journal Article
Closed access
PDF file
VGVivek Gavane
Vivek Gavane
SKShruti Koulgi
Shruti Koulgi
VJVinod Jani
Vinod Jani
MUMallikarjunachari V. N. Uppuladinne
Mallikarjunachari V. N. Uppuladinne
USUddhavesh Sonavane
Uddhavesh Sonavane
RJRajendra Joshi
Rajendra Joshi